ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 79 filers reported holding ANTARES PHARMA INC in Q3 2014. The put-call ratio across all filers is 37.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $62,000 | -67.2% | 19,186 | -71.2% | 0.00% | -60.0% |
| Q1 2017 | $189,000 | +81.7% | 66,717 | +48.8% | 0.01% | +66.7% |
| Q4 2016 | $104,000 | +57.6% | 44,836 | +13.6% | 0.00% | +50.0% |
| Q3 2016 | $66,000 | +6.5% | 39,453 | -23.1% | 0.00% | +100.0% |
| Q4 2015 | $62,000 | +138.5% | 51,333 | +237.4% | 0.00% | – |
| Q3 2015 | $26,000 | -27.8% | 15,216 | -12.1% | 0.00% | -100.0% |
| Q2 2015 | $36,000 | -52.0% | 17,312 | -37.8% | 0.00% | -50.0% |
| Q1 2015 | $75,000 | +70.5% | 27,814 | +62.4% | 0.00% | +100.0% |
| Q4 2014 | $44,000 | -75.7% | 17,126 | -82.6% | 0.00% | -66.7% |
| Q3 2014 | $181,000 | +2.3% | 98,634 | +94.4% | 0.00% | +50.0% |
| Q1 2014 | $177,000 | +149.3% | 50,728 | +220.6% | 0.00% | +100.0% |
| Q4 2013 | $71,000 | -76.5% | 15,824 | -78.7% | 0.00% | -75.0% |
| Q3 2013 | $302,000 | – | 74,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
| ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
| Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
| Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
| THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
| Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
| Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
| EAM Investors, LLC | 251,619 | $810,000 | 0.13% |